 |
Apomorphine hydrochloride |
|---|---|
| Trade Name | |
| Orphan Indication | For the treatment of patients in a vegetative state or minimally conscious state for up to 12 months following a severe traumatic brain injury (traumatic or spontaneous) |
| USA Market Approval | USA |
| USA Designation Date | 2006-05-23 00:00:00 |
| Sponsor | NeuroHealing Pharmaceuticals, Inc.;50 Undine Road;Newton, Massachusetts, 02135 |
